Researcher in lab

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 700 clinical trials open across 30 clinical units.

Find Melbourne Sexual Health Centre research studies and clinical trials
Clear filter
599 clinical trials found
Clinical trials

GOLDEN GATE

Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study) (NCT04994717)

Currently recruiting

GOlDiLOX

[NHL37] An open-label, single-arm, phase 2 trial of GlOfitamab anD pIrtobrutinib [LOXo-305] in patients with mantle cell lymphoma and prior exposure to a BTK inhibitor – GOlDiLOX (NCT05833763)

Currently recruiting

GS-US-536-5939

A Phase 2 Study of GS-5423 and GS-2872 in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults (NCT05729568)

Currently recruiting

GS-US-548-5916

GS-US-548-5916: A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma (NCT04854499)

No longer recruiting

GS-US-587-6156

A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) (NCT05330429)

No longer recruiting

GSK 219606

A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer (NCT05855200)

Currently recruiting

Guanethidine for PH-HFpEF

Guanethidine for Pulmonary Hypertension with Heart Failure with a Preserved Ejection Fraction [PH-HFpEF] (ACTRN12625000817448)

This study will help the researchers understand if guanethidine, a drug used to treat hypertension, is safe and effective in patients with PH-HFpEF.
Currently recruiting

H-MEET

Home-based Minimal Equipment Exercise Training (H-MEET) delivered using remote supervision: A randomised controlled feasibility study (ACTRN12625000550404)

Currently recruiting

HABOR

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis (HABOR) (NCT04910685)

Currently recruiting

HALEO

HALEO - A phase 3, multinational, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of NTLA-2002 in participants with hereditary angioedema [HAE] (NCT06634420)

Currently recruiting

HALFMOON

Evaluation of safety and performance of the Half Moon Transcatheter Mitral Valve Repair (TMVr) System in High Risk Patients with Severe Symptomatic Mitral Regurgitation. (ACTRN04343313)

Currently recruiting

HB-PD-002

Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (NCT05071430)

Currently recruiting

Hearts and Minds

Hearts and Minds: A 3-arm Multicentre, Randomised, Double-Blind, Placebo-Controlled Study of Metformin and Atorvastatin for the Treatment of Depression and Medical Comorbidity (ACTRN12623000611628)

Currently recruiting

HELIOS-B

HELIOS-B: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy) (NCT04153149)

Currently recruiting

Hexoskin study

Use of the Hexoskin shirt for assessment of patients with dysfunctional breathing compared to healthy controls (Trial Not Registered)

Coming soon

HIGHLIFE

Expanded study of the HighLife™ 28mmtranscatheter trans-septal mitral valve in patients with moderatesevere or severe mitral regurgitation and at high surgical risk (NCT04029363)

Currently recruiting

HOME-AKI

HOME-AKI: Haemofiltration with Oxiris: Multicentre Evaluation in Acute Kidney Injury (U1111-1247-3435)

Currently recruiting

HOV156

A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by one year maintenance in patients with newly diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic syndromes with excess blasts-2 (MDS-EB2) with FLT3 mutations eligible for intensive chemotherapy (NCT04027309)

Currently recruiting

I-MAT

A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma (NCT04291885)

Currently recruiting

IBIS

An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma incorporating Iberdomide, Isatuximab, and Dexamethasone (Iber-IsaDex) – the IBIS study (ACTRN12621001037897)

Currently recruiting
13 14 15 16 17